71 results
8-K
EX-10.2
ALIM
Alimera Sciences Inc.
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
, confidential, or proprietary information possessed by the Company or any of its affiliates, including trade secrets, customer or supplier lists, details
8-K
EX-10.1
ALIM
Alimera Sciences Inc.
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
or any of its affiliates, including Trade Secrets, customer or supplier lists, details of client or consultant contracts, current and anticipated
8-K
EX-10.2
ALIM
Alimera Sciences Inc.
12 Dec 23
Departure of Directors or Certain Officers
5:09pm
, or proprietary information possessed by the Company or any of its affiliates, including trade secrets, customer or supplier lists, details of client
8-K
EX-10.1
ALIM
Alimera Sciences Inc.
12 Dec 23
Departure of Directors or Certain Officers
5:09pm
of its affiliates, including trade secrets, customer or supplier lists, details of client or consultant contracts, current and anticipated customer
8-K
EX-10.1
mk0mtm1xoozi pfzp5
3 Oct 23
Alimera Sciences Appoints Jason Werner as Chief Operating Officer
7:00am
8-K
EX-10.2
rfv8bm
2 Aug 23
Unregistered Sales of Equity Securities
5:18pm
8-K
EX-2.1
or9 5t1m6kf
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
8-K
EX-10.4
819spu8
14 Apr 21
Alimera Sciences receives $20 million
9:12am
8-K
EX-99.1
cfop4em1t wgg
14 Apr 21
Alimera Sciences receives $20 million
9:12am